Breaking News

U.K. Bond Rating Affirmed at Aa1 by Moody’s After Scottish 'No' Vote
Tweet TWEET

MMRGlobal Retains Counsel in Australia and Issues Patent Update

MMRGlobal Retains Counsel in Australia and Issues Patent Update 
LOS ANGELES, CA -- (Marketwired) -- 06/03/13 --  MyMedicalRecords,
Inc. ("MMR"), a wholly owned subsidiary of MMRGlobal, Inc. (OTCQB:
MMRF), today announced that it has retained the legal firm of
Rockwell Olivier to represent the Company in Australia. Rockwell
Olivier will join MMRGlobal CEO Robert H. Lorsch in July for
licensing meetings in Australia. The firm will also represent MMR in
respect to the impasse concerning the possible exploitation of the
Company's MyMedicalRecords health IT Patents and Intellectual
Property by NEHTA and others. Rockwell Olivier is a full service law
firm with specialties in patent and trademark law. The firm has more
than 130 employees including 24 principals and 50 other associates.
Rockwell Olivier is headquartered in offices in Sydney and also
maintains offices in Perth, Melbourne, visiting offices in PNG, Fiji,
Vanuatu and a representative office in Singapore with affiliate
relationships in more than 15 countries across the Asia Pacific
Region. It had recently been brought to the Company's attention that
government bodies in Australia, through the National E-Health
Transition Authority (NEHTA), may have exploited the MMR patents
(including Australian patent numbers 2006202057 and 2008202401) and
other Intellectual Property (collectively, the "MMRIP") issued to
MyMedicalRecords.com, Inc. NEHTA has reportedly spent an estimated
one billion Australian dollars on an electronic Personal Health
Records program which is the subject of the potential exploitation of
the MMRIP.  
MMR is also updating shareholders on the status of patent litigation
domestically and licensing activities overseas. On January 31st,
MyMedicalRecords, Inc. announced the filing of a complaint for patent
infringement against Walgreen Co. The complaint alleges that
Walgreens is infringing on MMR's Personal Health Records patent,
specifically U.S. Patent No. 8,301,466, and as a result, MMR is
seeking monetary damages as well as a permanent injunction. As stated
in the complaint, Walgreens is the nation's largest drugstore chain
with fiscal 2012 sales of $72 billion, operating 8061 drugstores and
providing services to over 6 million customers. The complaint was
filed in the United States District Court for the Central District of
California, case number CV 13-00631, on January 29, 2013 and is
available on the court's website http://www.pacer.gov/. The
litigation is ongoing.  
On February 12, 2013, MyMedicalRecords, Inc. announced the filing of
a complaint for patent infringement against WebMD Health Corp. and
its wholly owned subsidiary, WebMD Health Services Group, Inc.
("WebMD"). The complaint alleges that WebMD is infringing on MMR's
Personal Health Records patents including U.S. Patent No. 8,301,466,
and as a result, MMR is seeking monetary damages as well as a
permanent injunction. The complaint was filed in the United States
District Court for the Central District of California, case number CV
13-00979 (CAS/JCx), on February11, 2013, and is available on the
court's website http://www.pacer.gov/. The parties have spent the
last three months in continued talks as discussed in the Company's
April 30th social media post at
https://www.facebook.com/MMRGlobal?ref=hl. Accordingly, the Company
expects to further update shareholders on the status of litigation by
June 6th due to court imposed deadlines which the Company plans on
meeting.  
On April 11, 2013, MMR also announced the filing of a complaint for
patent infringement against Quest Diagnostics, Inc. alleging that
Quest is infringing on MMR's Personal Health Records patent,
specifically, U.S. Patent No. 8,301,466, and as a result, MMR is
seeking monetary damages as well as a permanent injunction. The
complaint was filed in the United States District Court for the
Central District of California, case number CV-13-2538-CBM (MNx), on
April 10, 2013 and is available on the court's website
http://www.pacer.gov/. As stated in the complaint, pursuant to its
public records and statements, Quest is "the world's leading provider
of diagnostic testing services with a medical and scientific staff of
approximately 900 MDs and PhDs, an extensive network of convenient
patient locations and laboratories and a range of complementary
diagnostic products." According to the complaint, Quest offers a
product known as Gazelle, a mobile health application that is a PHR.
Gazelle allows a customer to receive and store through his or her
cell phone medical information, including personal medical records
amongst other things. It is still very early in the litigation,
however, the two companies are in communication.  
Lastly, on May 20, 2013, MMR announced the filing of a complaint for
patent infringement against Jardogs LLC, a subsidiary of Allscripts.
The complaint states that Jardogs provides health information
services to consumers and healthcare providers and is infringing on
MMR's Personal Health Records patents including U.S. Patent No.
8,301,466. According to the complaint, Jardogs provides a product
called FollowMyHealth(TM) Universal Health Record, which it describes
as the "next generation patient portal, combining patient-provider
communication with a patient managed personal health record." The
complaint alleges that Jardogs, while infringing on MMR's patent,
also has induced others including Allscripts, distributors, agents,
resellers and users to infringe one or more claims of the patent. MMR
is seeking monetary damages as well as a permanent injunction. The
complaint was filed in the United States District Court for the
Central District of California, case number CV: 13-3560, on May 16,
2013, and is available on the court's website http://www.pacer.gov/.  
MMR is a leading provider of Personal Health Records (PHRs),
MyEsafeDepositBox storage solutions, and MMRPro document management
and imaging systems for healthcare professionals. MMR currently has
seven U.S. Health IT patents: U.S. Patent Nos. 8,301,466; 8,352,287;
8,352,288; 8,121,855; 8,117,646; 8,117,045; and 8,321,240. The MMR
Patent Portfolio also includes additional applications and
continuation applications with nearly 400 claims. The patents involve
inventions pertaining to Personal Health Records, Patient Portals and
other Electronic Health Record systems. MMR also has been granted
patents and has other pending applications in countries of commercial
interest including Australia, Singapore, New Zealand, Mexico, Japan,
Canada, Hong Kong, South Korea, Israel, and European nations. 
On February 19, 2013, MMR announced that it has been brought to the
Company's attention that vendors providing services to the Ministry
of Health in Singapore appeared to be infringing on patents
(including Singapore patent number 200801954) and other Intellectual
Property issued to MyMedicalRecords, Inc. The Company has been
advised that personally-controlled health records, or Personal Health
Records, are included in programs for the Ministry of Health, the
Health Promotion Board, the Health Sciences Authority and numerous
other organizations in Singapore, which the Company believes is
clearly part of MMR's inventions that led to its MyMedicalRecords
patents. The Company has spoken with vendors and others in Singapore
and is optimistic that as a result of its patents it can find
licensees in the region to offer its IP. 
The Company also recently announced relationships with
representatives in the Middle East and potential licensees in Japan
where the Company believes recent patent awards represent a
significant opportunity at this time.  
For additional information regarding the MyMedicalRecords, Inc.
patent litigation matters, contact Ted Ward at Liner Grode Stein
Yankelevitz Sunshine Regenstreif & Taylor LLP at (310) 500-3384. 
About MMRGlobal
 MMRGlobal, Inc., through its wholly-owned operating
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients through an integrated patient portal.
Through its merger with Favrille, Inc. in January 2009, the Company
acquired intellectual property biotech assets that include anti-CD20
antibodies and data and samples from its FavId(TM)/Specifid(TM)
vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's
lymphoma. To learn more about MMRGlobal, Inc. visit
www.mmrglobal.com. View demos and video tutorials of the Company's
products and services at www.mmrtheater.com. 
Forward-Looking Statements 
 All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property licenses, property enforcement
actions, infringement claims or litigation, and future performance,
management's expectations, beliefs, intentions, estimates or
projections, constitute "forward-looking statements." Such
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the Company's actual
results to be materially different from historical results or from
any results expressed or implied by such forward-looking statements.
Some can be identified by the use of words (and their derivations)
such as "need," "possibility," "potential," "intend," "offer,"
"development," "if," "negotiate," "when," "begun," "believe,"
"achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue," or the negative of these words. Actual outcomes and
results of operations and the timing of selected events may differ
materially from the results predicted, and any reported results
should not be considered as an indication of future performance. Such
statements are necessarily based on assumptions and estimates and are
subject to various risks and uncertainties, including those relating
to the possible invalidity of the underlying assumptions and
estimates and possible changes or developments in economic, business,
industry, market, legal and regulatory circumstances and conditions
and actions taken or omitted to be taken by third parties, including
customers, suppliers, business partners, potential licensees,
competitors and legislative, judicial and other governmental
authorities and officials. Factors that could cause or contribute to
such differences include, but are not limited to: unexpected outcomes
with respect to intellectual property enforcement actions, claims of
intellectual property infringement and general intellectual property
litigation in the U.S. and internationally; our ability to maintain,
develop, monetize and protect our patent portfolio for both the
Company's health IT and biotechnology intellectual property assets in
the U.S. and internationally; the timing of milestone payments in
connection with licensing our intellectual property; our ability to
establish and maintain strategic relationships; changes in our
relationships with our licensees; the risk the Company's products are
not adopted or viewed favorably by the healthcare community and
consumer retail market; business prospects, results of operations or
financial condition; risks related to the current uncertainty and
instability in financial and lending markets, including global
economic uncertainties; the timing and volume of sales and
installations; the length of sales cycles and the installation
process; the market's acceptance of new product and service
introductions; competitive product offerings and promotions; changes
in government laws and regulations and future changes in tax
legislation and initiatives in the healthcare industry both in the
U.S. and internationally; undetected errors in our products; the
possibility of interruption at our data centers; risks related to
third party vendors; risks related to obtaining and integrating
third-party licensed technology; risks related to a security breach
by third parties; risks associated with recruitment and retention of
key personnel; other litigation matters; uncertainties associated
with doing business internationally across borders and territories;
and additional risks discussed in the Company's filings with the
Securities and Exchange Commission. The Company is providing this
information as of the date of this release and, except as required by
applicable law, does not undertake any obligation to update any
forward-looking statements contained in this release as a result of
new information, future events or otherwise.  
MEDIA CONTACTS 
MMRGlobal: 
Michael Selsman
Public Communications Co.
ms@publiccommunications.biz
(310) 922-7033 
Rockwell Olivier: 
Vivienne Story
Rockwell Olivier (Sydney) Pty Ltd 
vstorey@ro.com.au
+61 2 8263 6600 
 
 
Press spacebar to pause and continue. Press esc to stop.